International Society for Pharmacoepidemiology
 
International Society for Pharmacoepidemiology

15th International Conference on Pharmacoepidemiology

August 26th-29th, 1999
Westin Copley Place
Boston, MA

General Information   ·   Program Schedule
Previous Conferences   ·   Future Conferences

Poster Sessions

Posters should be mounted by 8:30 am and removed by 4 PM each day. Poster sessions will be moderated. Poster presenters should be at their posters from 12:00 to 2:00 on the day of presentation. Your poster number is the number listed in the first column. Your abstract number, for use in locating your paper in the journal, is in [ ] after the title of your poster.


FRIDAY, AUGUST 27

Poster Session A
Moderators:
Bert Leufkens, Brian Strom, Bram Hartzma, Ulf Bergman

1 The most common indications for antibiotic prescribing: A study using the General Practice Research Database (GPRD) [18]
SR Chapman, M Frischer (UK)
2 Explaining variation in practice prescribing of hormone replacement Therapy in the UK: a study using a geographic information system [19]
HF Heatlie, SR Chapman (UK)
3 Epidemiology and pharmacological treatment of tinnitus in Germany [86]
R Rychlik, M Pilgram, H Siedentop, D Kirchhoff (Germany)
4 The treatment of recurrent otitis externa in general practice [94]
S Rowlands, H Devalia, A Dean (UK)
5 The prescribing use of lipid lowering drugs during a one year period. An analysis of 7490 health insurance files [96]
J Krappweis, D Aumann, U Schwarz, W Kirch (Germany)
6 Pharmacologic treatment of people with Parkinson's Disease living in long-term care. [101]
K Lapane, H Fernandez, J Friedman (USA)
7 Management of diabetes in long term care [104]
J Spooner, K Lapane, A Hume, V Mor (USA)
8 A comparative study of the quality of information provided by pharmacies for the resolution of diarrheal episodes in children under 5 years of age in the municipalities of Corumbá and Ladário, Brazil 1998-99 [114]
M de Lourdes Oshiro, L Lusitana Cardozo de Castro (Brazil)
9 The daily practice of antibiotic prescription in public health units in Araraquara, SP, Brazil, 1997 [116]
MJS Simões, C Fegadolli (Brazil)
10 Wide variation in the number of different drugs prescribed by general practitioners [131]
L Bjerrum (Denmark), U Bergman (Sweden)
11 OBRA Guidelines: How do community prescribers compare? [141]
B Dellasega, D Orwig, D Heller (USA)
12 Patterns of contraception in UK women with Type 1 diabetes: a GP Database study [143]
R Lawrenson, T Williams, G Leydon, R Newson (UK)
13 The treatment of depression in the UK general practice: selective Serotonin reuptake inhibitors and tricyclic antidepressants compared [144]
R Lawrenson, FTyrer, R Farmer (UK)
14 Use of gastrointestinal (G) protective agents among patients on Nonsteroidal antinflammatory drugs in France [159]
N Moore, C Montout, X Verschuren, J Callens, B Bégaud (France) SKong (USA)
15 Antibiotic prescribing for upper respiratory infections in children [196]
C Waning, S Lesko, A Mitchell (USA)
16 Variability in prescribing patterns in children with sore throat in the USA. [197]
J Daniel, S Lesko, A Mitchell ( USA)
17 Risk management strategies to improve the quality of ACE inhibitor therapy in family medicine practice: A DATIS practice assessment programme [210]
J Braddon, K Charlesworth, J Gailer, F May, D Rowett (Australia)
18 An investigation into the prescribing patterns of gastroprotective agents in a South African arthritic population [211]
R Wiseman, I Truter, (South Africa)
19 Patterns of Antidepressant prescribing in an elderly South African Population [212]
M Bellingan, I Wiseman, I Truter (South Africa)
20 The incidence, natural history and treatment of chickenpox in a large automated paediatricians' database (Pedianet) in Italy [237]
D Giaquinto, MCJM Sturkenboom, L Cantarutti, U di Luzio Paparatti, F Arpinelli (Italy)
21 A pharmacoepidemiological investigation into the drug management of four chronic disease states in South Africa [240]
I Truter, J Serfontein, T van W. Kotze (South Africa)
22 Oral antidiabetic drug prescribing patterns in South Africa: A prescription database analysis [241]
I Truter, DJL Venter, JHP Serfontein (South Africa)
23 Determinants of psychotropic drug usage in a general intensive care unit [246]
J Stolker, E Heerdink, S Pullen, F Santman, Y Hekster, H Leufkens (The Netherlans)
24 A study of multiple prescriptions of antibiotics for 0 - 5 year old children in relation to type of antibiotic [271]
N Thrane, C Olesen, H Schønheyder, H Sørensen (Denmark)
25 Effects of Fluoxetine for the treatment of masked depression in the elderly [279]
Y Du, W Zhuang, A Zheng, Y Wang (China)
26 Analysis of Benzodiazepine-prescribed prescriptions for outpatients in a general hospital [282]
W Zhuang, Y Du, Z. Geng, Y Wang (China)
27 Post-marketing surveillance of a low dose oral contraceptive containing the hybrid progestin Dienogest (DNG) in combination with Ethinylestradiol (EE) [7]
H Hoffmann, T Zimmermann, H Dietrich, K Wiser, B Felsch (Germany)
28 Incidence of adverse drug reactions leading to hosptial admissions: combining sentinel-based pharmacovigilance with drug utilization data [15]
S Schneeweiss, J Hasford, M Göttler, W Swoboda, M Hippius, A Riethling, J Krappweis (Germany)
29 Maximising signal evaluation through efficient use of resources [41]
S Davis, R Coulson (UK)
30 Churg Strauss Syndrome: an unexpected adverse reaction with anti-asthma drugs? [42]
P O'Mahony, P Arlett, E Lee (UK)
31 Agranulocytosis with anti-thyroid drugs: the value of routine full blood count monitoring [43]
S Bhasin, P Arlett, E Lee (UK)
32 Review of SSRI safety information [44]
I Douglas, E Major, S Morris, S Wark (UK)
33 Use of a large spontaneous reporting database to validate suspected differences in reporting of vaginal bleeding as an adverse reaction between types of hormone replacement therapies [45]
M Taherzadeh, S Davis, E Brown (UK)
34 Multiple spontaneous adverse event reports from a single reporting region - implications for increased frequency analyses [49]
J Clark, S Klincewicz (USA)
35 Poliovirus vaccine adverse events surveillance - the Vaccine Adverse Events Reporting System (VAERS) [58]
W Wattigney, G Mootrey, M Braun, R Chen (USA)
36 Analysis of the occurrence of Weber Effect in spontaneous adverse event reporting [73]
M Fung, K Kwong, C Mockbee, K Hornbuckle, E Muniz ( USA)
37 Impact of underreporting on the utility of spontaneous adverse events reporting in postmarketing drug surveillance [74]
M Fung, S Bates, K Li, K Hornbuckle, E Muniz (USA)
38 Experience of fexofenadine and cardiac side effects in general practice use in England [78]
P Craig-McFeely, S Freemantle, G Pearce, R Mann (UK)
39 Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression [79]
N Dunn, S Freemantle, R Mann (UK)
40 Post marketing surveillance of meloxicam: prescription - event monitoring observational cohort study in 19,087 users in general practice in England [80]
P Biswas, L Wilton, R Martin, S Freemantle, G Pearce, R Mann (UK)
41 A descriptive epidemiological study of Hypotonic Hyporesponsive Episode (HHE) reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998 [112]
T DuVernoy, M Miles Braun (USA)
42 Anaphylactoid reactions to contrast media. Do b-Blockers and Calcium Antagonists influence their severity? [115]
A Michel, A Alhassan, H-J Maurer, W Schumann (Germany)
43 Adverse drug reactions in children: an active monitoring system in Italy [118]
E Menniti-Ippolito, R Raschetti, C Gianquinto, L Cantarutti (Italy)
44 Reactivation of herpes infections after vaccinations? Alerts from spontaneous reports and hypothesis testing [123]
K Hartmann, , R Walter, M Kuhn (Switzerland) V Pool, P Gargiullo ( USA)
45 Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) reports to the Vaccine Adverse Event Reporting System (VAERS) [124]
L Ball, R Ball, R Wise, M Braun, J Beeler, M Salive (USA)
46 Fake drugs in Nigeria [129]
O Ogbeide, O. Ogbeide (Nigeria)
47 Liver damage associated with minocycline: a systematic review of the literature [142]
H Seaman, A Sundström, T Williams, R lawrenson, R Farmer, (UK)
48 Anti-Hypertensive effectiveness and tolerability in an observational epidemiological follow-up [149]
P Aranda, A de la Sierra, M Rufino, I Lázaro, J Salvador López, J Lluís Segú (Spain)
49 Neuro-psychiatric adverse effects attributed to mefloquine - a follow up of 327 reports from 1992-1996 [152]
M van Riemsdijk, A Slappendel, MCJM Sturkenboom, L Pepplinkhuizen (The Netherlands)
50 Effectiveness and safety of Roxatidine in the treatment of symptoms due to acid-related gastrointestinal disorders [155]
J Monés, J López-Agustina, J Segú (Spain)
51 An analytical algorithm to distinguish vaccine-related adverse events from usual medical events in vaccine post-marketing safety studies using computerized databases [57]
P Coplan, H Shinefield, P Ray, N Lewis, J Hansen, R Sharrar, H Guess (USA)
52 Serious adverse drug reactions in general practice: an incidence study in Aquitaine (south-west France) [160]
C Lacoste-Roussillon, P Pouyanne, B Bégaud ( France)
53 Arthralgia, fever and urticaria associated with terbinafine: sysmptoms or syndrome? [173]
E van Puijenbroek, A Egberts, H Leufkens (The Netherlands)
54 Concomitant use of diuretics and non-steroidal anti-inflammatory drugs increase the risk of signs of congestive heart failure: evidence from a spontaneous reporting system [174]
E van Puijenbroek, A Egberts, H Leufkens (The Netherlands)
55 Characteristics of ADR-reporting by pharmacists in the Netherlands [175]
A van Grootheest, E van Puijenbroek (The Netherlands)
56 Risk factors for the most serious VAERS reports [186]
W Kelly, G Mootrey, P Gargiullo, T Strine, R Chen ( USA)
57 Hepatic reactions and lupus-like syndrome associated with minocycline in the WHO ADR-databse [215]
A Sundström, H Seaman, R Lawrenson, R Farmer, (UK) M Lindquist, (Sweden)
58 Effect of patient monitoring program on the risk of Clozapine-induced agranulocytosis in Argentina [259]
E Giménez, M Bignone, R Bolaños, M Fopplano, P Saldón, S Corazza, P Bazerque (Argentina)
59 A retrospective study on Esophageal Stricture and the use of Alendronate [278]
QY Yue, Ö Mortimer (Sweden)
60 Use of Tielopidine and Clopidogrel in Association with Coronoary Procedures
A Brinker, D Sharin, W Ray, KA Chan (USA)
61 HMG CoA Reductase Inhibitors and Cancer - A Meta Analysis
L Bjerre, J LeLorier (Canada)
62 Retrospective study comparing cost-effectiveness of newer amphoteracin B Preparations
K Mamzoridi

SATURDAY, AUGUST 28

Poster Session B
Moderators:
Anick Berard, Judith Jones RMC Herings, Bength-Eric Wiholm

1 Utilization review of inhaled B2-agonists in the treatment of asthma [3]
JP Grégoire, R Blais, D Blais, D Doyon (Canada)
2 Prevelance of use of infertility treatments [9]
M Maggini, S Spila-Alegiani, R DaCas, G Traversa (Italy)
3 Educational outreach in nursing homes [20]
S Chapman, H Boardman, V Thompson (UK)
4 Prevalence and trends in use of corticosteroids, disease-modifying anti-rheumatic drugs (DMARDs) and non-steroidal anti-inflammatory drugs (NSAIDs)in rheumatoid arthritis [29]
A Bérard, D Solomon, J Avorn ( USA)
5 The diffusion of a novel therapy into general medical practice: the case of Sildenafil [31]
L Harrold, J Gurwitz, T Field, S Andrade, L Fish, P Jarry, R Yood (USA)
6 Evaluation of a comprehensive formulary switch in the managed care setting: the case of hormone replacement therapy [32]
S Andrade, J Gurwitz, L Fish, J Cernieux, R Yood ( USA)
7 The use of gastrointestinal agents in long term care facilities [36]
S Weiss, I Zuckerman, VD Hsu (USA)
8 Hospitalization and mortality among elderly medicaid psychotropic drug users [38]
R Paulose, F Ahern, D Heller, D Barro (USA)
9 Impact of prospective drug use review on health outcomes among the elderly [39]
F Ahern, D Heller, R Paulose, D Barro (USA)
10 Drug Utilization patterns for flu or flu-like illness in primary care in the UK [48]
A Meier, P Napalkov, Y Wegmüller (Switzerland) J Jefferson (UK)
11 Prevalence and treatment of COPD in Spain [50]
J Segú, M Miravitlles, J Masa, R Gabriel, C Villasante, C Jiménez, J Viejo, L Fernández-Fau, V Sobradillo ( Spain)
12 Target US population for Lipid-lowering therapy based on Adult Treatment Panel II guidelines and Ntional Health and Nutrition Examination Survey III Date ( 1988-1994) [56]
T Jacobson, G Griffiths, D Gause, J Sung, C Ballantyne (USA) , C Varas (Spain)
13 Patterns of use of Amlodipine and Felodipine in Quebec elderly [62]
O Sheehy, J LeLorier (Canada)
14 Drug utilization profile of the combination use of SSRI antidepressants and Atypical Antipsychotics [70]
M Fung, B Aguirre, K Hornbuckle, E Muniz ( USA)
15 Continuous use of over-the-counter drugs: results from a population based study [84]
S Sihvo, T Klaukka, J Martikainen, E Hemminki (Finland)
16 Oral contraceptive utilisation patterns from 1992 to 1997. The effect of the October 1995 CSM notice on prescribing of Desogestrel and Gestodene based products in the UK [85]
T Williams, R Lawrenson, R Farmer ( UK)
17 Comparison of safety profiles of Acetaminophen dosing regimens (3G and 4G daily) in patients with painful chronic rheumatoid diseases [126]
D Vesque, J Dardennes, H Ganry, A Pelc, F Pruvot, N Schmidely (France)
18 Utilization and cost comparison of inpatient antidepressant drugs [127]
D Ackerman, A Bystritsky, M Gitlin ( USA)
19 Pharmacological therapy of essential hypertension: the National Ambulatory Medical Care Survey, 1996 [132]
B Huang, K Bachmann, R Chen, J McAllister ( USA)
20 An assessment of drug use in selected health institutions in Addis Ababa [135]
A Menkr (Ethiopia)
21 Use of nonsteroidal anti-inflammatory drugs and adverse drug reactions: a study in French general practioners and rheumatologists [158]
N Moore, X Verschuren, C Montout, J Callens, B Bégaud (France) S Kong (USA)
22 Verbal and written information to triptan users. A randomised, controlled trial on the effect on consumption [169]
J Sondergaard, M Andersen, J Kragstrup, B Larsen, L Gram, D Gaist, S Sindrup, H Schaffalitzky de Muckadell (Denmark)
23 Different patterns of lipid-lowering drug use in Funen, Denmark and Bolgna, Italy [170]
J Larsen, M Andersen, U Bergman (Denmark), A Vaccheri, N Montanaro (Italy)
24 Trends in the use of anti-tuberculosis drugs in Spain: 1993-1997 [171]
A Blázquez Pérez, R Mateos Campos (Spain)
25 Use of asthma medications in a US managed care population [178]
J Castellsague (Spain), J Prescott, Y Svirnovskiy (USA)
26 The use of asthma medication in Denmark [187]
BK Ingvardsen, L Sørensen (Denmark)
27 The use of Viagra in Denmark in the period October-December 1998 [188]
BK Ingvardsen, C Ranneries (Denmark)
28 Use of menopausal estrogens in Saskatchewan: 1984 to 1994 [201]
I Csizmadi, J Collet, A Benedetti, J Hanley, J Boivin (Canada)
29 Cytomegalovirus (CMV) infection in single solid organ transplants: risk stratification for CMV status of donor and acceptor [204]
RH Vander Stichele, MM Elseviers, R Peleman (Belgium)
30 Low use of medications for symptomatic treatment of Alzheimer's dementia in Sweden in 1998 [206]
U Bergman, A. Leimanis (Sweden)
31 Drug utilization review of Cephalosporins in the geriatric inpatients in Korea [208]
BJ Park, YK Cho (Korea)
32 Prescription drug use and health care utilization among the elderly general population in the UK [213]
A Kennerfalk, S Johansson, MA Wallander (Sweden), A Ruigomez (Spain)
33 Evolution of total and cardiovascular prescriptions in individuals over and under 60 years. Argentina 1988-1992 - possible influence of economic crisis [216]
R Bolaños, C González, K Prieto, L Nudelman, L Arias (Argentina)
34 Analysis of the profile of drug utilization in blood donnor preliminary report [217]
R Bolaños, L Calderone, G Worcel, L Nudelman, C Bernao (Argentina)
35 An investigation into the treatment of female patients with Osteoporosis using drug utilisation consumption parameters [242]
I Truter, JHP Serfontein (South Africa)
36 Discontinuation patterns in patients using new antidepressants [244]
WEE Meijer, ER Heerdink, JTM van Eijk, L Pepplinkhuizen, HGM Leufkens (The Netherlands)
37 Sex differences in the medication choice for hypertension in general practice. A study with written case simulations [250]
OH Klungel, AHP Paes, A deBoers, MM Kuyvenhoven, JC Seidell, A Bakker (The Netherlands)
38 Pattern of use of incontinence drugs in Quebec elderly [265]
A Desgagné, J LeLorier (Canada)
39 Use of Fentanyl and Midazolan in critical children patients in the pediatric intensive treatment unit of the Children's Hospital of Brasilia [268]
MM Meiners, MF Dias, CCF Vidotti, AP Serafim, GBB Mendes (Brazil)
40 Antibacterial drug use in a university teaching hospital in Oman [269]
L Bruno, KA Al-Riyamy, IS Al-Zakwani, AO Isah, BM Al-Riyami (Oman)
41 Asthma medications during pregnancy; fetal growth and adverse fetal outcomes [270]
C Olesen, N Thrane, G Lauge Nielsen, H Toft Sørensen, J. Olsen (Denmark)
42 Drug use pattern in a primary care setting in Oman [277]
KA Al-riyamy, AO Isah, IS Al-Zakwani, L Bruno, BM Al-Riyami (Oman)
43 Utilization of drugs in Iran during 1997-98 [281]
F Ansari ( Iran)
44 Cost of managing constipation in cancer patients receiving oral morphine or transdermal Fentanyl in Ontario, Canada [8]
T Flynn, J Guest (UK)
45 Adverse drug reaction monitoring - length of stay of ADR admissions to hospital [11]
A Hoffmann, M Hippius, H Filz, T Sicker (Germany)
46 Anemia in arthritis patients [16]
S Zhao, L Arguelles MS Seema, D Dedhiya (USA)
47 Should post-menopausal woemn with rheumatoid arthritis starting steroids be screened for Osteoporosis? A cost-effectiveness analysis [23]
D Solomon, K Kuntz (USA)
48 Costs derived from treatment of acute exacerbations of chronic bronchitis in primary care [53]
JL Segú, M Miravitlles, C Murio, T Guerrero (Spain)
49 Savings in direct medical costs produced by an inhaled solution of Tobramycin (Tobi) in children with Cystic Fibrosis [61]
J LeLorier, S Perreault (Canada), H Birnbaum, P Greenberg (USA)
50 Cost associated with discontinuation of Antihypertensive drug therapy in a medicaid population [87]
M Nicol, F Venturini, J McCombs, N Sengupta, T Kamath, R Tannous (USA)
51 Opioid Analgesics use in patients with non-malignant pain: comparison of Duragesic and other Opioids [108]
J Loughlin, A Walker, J Alexander Cole, J Wilson, S Dodd, AM Sesti (USA)
52 Drug use and costs in a very old population [125]
J Fastbom, M ST Giron (Sweden)
53 Pharmacoepidemiologic study of antimicrobial therapy in the treatment of community-acquired pneumonia [137]
O Karpov, A Zaytsev, E Maximenko, Y Ignatov (Russia)
54 Factors predicting lack of improvement when treating acid-related complaints with Roxatidine [148]
J Monés, JS López-Agustina, JL Segú (Spain)
55 Cost-benefit analysis of an incentive scheme for promoting rational antibiotic prescribing [166]
A Riewpaiboon, V Tangcharoenstnien (Thailand) PR Passmore, VB Sunderland (Australia)
56 Estimating the risk of gastrointestinal perforations, ulcers and bleeds (PUBs) in populations not exposed to NSAIDs: a meta-analysis [198]
W Strau, J Ofman, C Maclean, S Morton, E Roth, M Berger, P Shekelle (USA)
57 Does payment based on diagnosis-related groups cover therapy costs? [221]
C Venanzi, R Arboretti, F Venturini, R DiVirgilio, M Romero (Italy)
58 Treatment of childhood and adolescent depression in a medicaid program [260]
TP McLaughlin, R Schulz (USA)
59 Impact of the Quebec General Drug Insurance Plan on the monthly dispensed prescriptions of 4 classes of medication [66]
L Blais, JM Boucher, J Couture, E Rahme, J LeLorier (Canada)
60 The impct of legislation on psychotropic drug use in nursing homes: a cross-national comparison [102]
C Hughes (Ireland), K Lapane, V Mor (USA)
61 Pharmacotherapeutic evaluation of dutch hospital drug formularies [182]
R Fijn, SAF Engels, JRBJ Brouwers, RJ Knaap, LTW de Jong-Van den Berg (The Netherlands)
62 Thalidomide: monitoring a unique regulatory approach [205]
CM Van Bennekom, AA Mitchell (USA)
63 Assessment of obesity social impact in Spanish population [51]
M Barbany, M Carrillo, X Remesar, X Formiguera, J Segú, F Armero, M Foz (Spain)
64 Low self-awareness of obesity in Spanish population [52]
M Carrillo, M Barbany, X Remesar, X Formiguera, J Segú, F Armero, M Foz (Spain)
65 Reports of death in Viagra users
D Wysowski, E Farinas, M Hirsch, T Piazza-Hepp, Y Tsong, M Mann, E Rodriguez (USA)

SUNDAY , AUGUST 29

Poster Session C
Moderators:
Sean Hennessy, Lolkje de Jong Van den Berg Yola Morida, Alec Walker

1 Evaluation of association between Indinavir therapy for HIV/AIDS and myocardial infarction in 4 clinical trials (N=2,825) [2]
P Coplan, A Nikas, A Saah, M Nessly, L Doll, R Leavitt, J Benson, H Guess (USA)
2 Risk of VTE in users of postcoital contraceptive pills [12]
C Vasilakis, S Jick, H Jick (USA)
3 Tramadol and suicidal tendencies [13]
C Vasilaksi, H Jick (USA)
4 The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer [14]
P Coogan, L Rosenberg, R Sowmya Rao, J Palmer, S Shapiro (USA)
5 Hip fracture risks with sedative hypnotic use in elderly patients [22]
P Wang, R Bohn, R Glynn, H Mogun, J Avorn (USA)
6 Paradoxical relationships of drug treatment with mortality in the elderly [26]
R Glynn, E Knight, R Levin, J Avorn (USA)
7 Reliability of Chalmers Scale to assess quality in meta-analyses on pharmacological treatments of Osteoporosis [28]
A Bérard (USA), N Andreu, JP Tétrault, T Niyonsenga, D Nyhal (Canada)
8 Risk factors for adverse drug events among nursing home residents [33]
T Field, J Gurwitz, J Avorn, D McCormick, S Jain, M Eckler, M Benser, D Bates (USA)
9 Incidence and preventability of adverse drug events in the nursing home setting [34]
J Gurwitz, T field, J Avorn, D McCormick, S Jain, M Eckler, M Benser, D Bates, M Meyers (USA)
10 Short-term safety and tolerability of Antihypertensive agents in Korean adults [40]
YS Kim, HS Park, S Sunwoo, JJ Byeon, YM Song, HG Seo, CH Kim KS Cheon, SM Yoo, JK Lee (Korea)
11 Use of calcium channel blockers and beta blockers as antihypertensives in relation to causes of death in type 2 diabetes patients [46]
G Lindberg, J Olsson, A Melander (Sweden)
12 Effects of Aspirin and nonsteroidal anti-inflammatory drugs on the incidence of myocardial infarction in a cohort of postmenopausal women [55]
C Vara-Lorenzo, LA Garcia-Rodriguez, S Perez-Gutthann (Spain), C Patrono (Italy)
13 Absence of an association between osteoporotic fractures and oral anticoagulants among elderly patients in Québec [65]
D Pilon, AM Castilloux, J LeLorier (Canada)
14 Automated safety signal evaluation tool (ASSET) - an innovative program for drug safety monitoring [71]
M Fung, K Hornbuckle, A Thornton, J Wang, E Muniz (USA)
15 Visual field defects in patients on long term Vigabatrin treatment [77]
LV Wilton, MDB Stephens, R Mann (UK)
16 Risk of myocardial infarction associated with smoking, and use of oral contraceptives, in young women in the United Kingdom [81]
N Dunn, R Mann (UK)
17 Prospective observational study to monitor the introduction of Ventolin Evohaler in English general practice. Interim report [82]
PM Craig-McFeely, N Dunn, GL Pearce, SL Freemantle, RD Mann (UK)
18 One year follow-up of newly diagnosed irritable bowel syndrome patients [88]
A Ruigómez, LA García Rodríguez (Spain), MA Wallander, S Johansson (Sweden)
19 Incidence of irritable bowel syndrome and functional dyspepsia and risk of colorectal polyp and cancer in these two populations [89]
LA García Rodríguez, A Ruigómez (Spain), MA Wallander, S Johansson (Sweden)
20 Multiple course antenatal steroids are independently associated with increased mortality in neonates born at less than 28 weeks gestation [91]
GA Macones, B Banks, A Cnaan, D Stamilio, J Merrill, MA Morgan, J Parer, N Stouffer, R Ballard (USA)
21 A drug-safety study to examine the possible association of acute renal failure with dispensed nabumetone, ibuprofen and other non-steroidal anti-inflammatory drugs [97]
PT Donnan, TM MacDonald (UK)
22 A drug-safety study to examine the possible association of congestive heart failure with dispensed nabumetone, ibuprofen and other non-steroidal anti-inflammatory drugs [98]
PT Donnan, JGF Cleland, TM MacDonald (UK)
23 A drug safety study to examine the possible associations of G.I. events with dispensed nabumetone, ibuprofen and other non-steroidal anti-inflammatory drugs [99]
PT Donnan, TM MacDonald (UK)
24 The effect of NSAIDs on the rate of hospitalization for gastrointestinal ulcers among residents living in long term care [105]
K Lapane, L Mucha, S Gonzalez, J Spooner, W Straus (USA)
25 Cognitive function as predictor of compliance in elderly patients with hypertension [106]
M Salas, BA In't Veld, PD van der Linden, A Hofman, BHCh Stricker (The Netherlands)
26 Recent incidence of post transplant lymphoproliferative disorder (PTLD) among renal transplant patients in the US. [109]
D Funch, JM Cecka, S Sagiv, N Dreyer, A Walker (USA)
27 Post-marketing evaluation of short term safety of COMVAX vaccine: a report on the first 6 months [110]
RL Davis, P Lee Poy, A Zavitkovsky (USA)
28 Pre- and Post-operative medication and renal impairment after joint replacement due to osteoarthritis [117]
T Stürmer, A Erb, KP Günther, H Brenner (Germany)
29 Non A non C hepatitis and drug use [119]
G Traversa, M Ciccozzi, A Mele (Italy)
30 The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus [121]
DF Lehmann, A Liu, N Newman, DC Blair (USA)
31 Drugs as a risk factor for delirium in the elderly [128]
Y Morida, G Galbaud du Fort, JF Boivin, M Cole, S Vida, J McCusker, J LeLorier, J Monette (Canada)
32 Use of oral corticosteroids and risk of fractures [136]
TP van Staa, C Cooper (UK) , L Abenhaim(Canada), B Begaud (France), H Leufkens (The Netherlands) JJ Vieira Teixeira, LL Cardoso de Castro, F Lefèvre (Brazil)
33 A large scale randomized clinical trial comparing the tolerability of ibuprofen, paracetamol and aspirin for short-term analgesia: methodological aspects and overall results [140]
N Moore, E Van Ganse, JM Le Parc, F. Pelen, H Schneid, F Verrière (France) , R. Wall, M Farhan (UK)
34 Coronary heart disease in women with diabetes: positive association with past hysterectomy and possible benefits of hormone replacement therapy [146]
RA Lawrenson, GM Leydon, RB Newson, MD Feher (UK)
35 Correlates of inappropriate prescribing in patients aged ³65 years in the USA [147]
GM Batty, CA Oborne, KL Minaker, SHD Jackson, CG Swift, D Harari (UK)
36 Confounding by contraindication in a study on mortality risk of Ibopamine use [151]
J Feenstra, BA In't Veld, DE Grobbee, BHCh Stricker (The Netherlands)
37 Intraocular pressure elevation and use of corticosteroids: the Rotterdam Study [153]
MM van Riemsdijk, Y Yang, R Ramrattan, MCJM Sturkenboom, PTVM de Jong, BHCh Stricker (The Netherlands)
38 Benzodiazepines and the risk of hip fracture: a case-control study [156]
C Pierfitte, A Chaslerie, F Pehourcq, M Thicoïpe, M Aïssou, B Bégaud, J Dangoumau, N Moore (France)
39 Intentional drug overdose: validity of the information sources on drugs in comparison with plasma data [157]
MD Matskia, N Moore (France)
40 Do Benzodiazepines increase the risk of dementia in the elderly? A nested case-control study [161]
R Lagnaoui, B Bégaud, A Fourrier, L Letenneur, N Moore (France)
41 Comparison between the observed and expected number of cases: application for the treatment of signals in Pharmacovigilance [162]
A Fourrier, E Touzé, A Alpérovitch, B Bégaud (France)
42 Association between hepatitis B vaccine and multiple sclerosis: a case control study [163]
A Fourrier, E Touzé, A Alpérovitch, B Bégaud (France)
43 Urological complaints in relation to indinavir plasma concentration in HIV-infected patients [167]
JP Dieleman, IC Gyssens, ME vd Ende, S de Marie, DM Burger, MJCM Sturkenboom (The Netherlands)
44 Determinants for potentially toxic theophylline serum concentrations [172]
PJM Schmitz, CMJM Gerrits, ACG Egberts (The Netherlands)
45 Is there an increased risk for benign liver tumours in users of modern oral contraceptives? [190]
L Heinemann, E Garbe, A Weimann, G Gerken , M Schlaud (Germany)
46 Oral progestogen- only contraceptives and cardiovasular risk [191]
L Heinemann, A Assmann, T DoMinh, E Garbe (Germany)
47 Acute myocardial infarction in relation to antihypertensive agents: history of drug use as a determinant of risk [199]
C Bourgault, S Suissa (Canada)
48 First-time use of anti-hypertensives and the risk of hypoglycemia in patients with diabetes [200]
S Cowan, S Suissa (Canada), E Garbe (Germany)
49 A detailed examination of fenfluramine-phentermine users with valve abnormalities identified in Fargo, North Dakota [202]
S Kimmel, M Keane, J Crary, J Jones, J Kinman, J Beare, M Sammel, M St. John Sutton, B Strom (USA)
50 New drug starts and risk of falls in nursing homes [203]
C Ineke Neutel, S Desjardins-Denault, C Maxwell (Canada)
51 The risk of malignant liver tumors in patients treated with potentially hepatotoxic drugs. A case-control study [214]
M Follmann, LAJ Heinemann, A Bauer-Feind, E Garbe (Germany)
52 Etidronate use is not associated with subsequent symptoms of peptic ulcer disease. [219]
H Burger, RMC Herings, ACG Egberts, C Neef, HGM Leufkens (The Netherlands)
53 Hight estrogen load from oral contraceptives increases breast cancer risk in women over 55 years of age: The Dom Cohort [220]
C van Hoften, H Burger, PHM Peeters, DE Grobbee, PAH van Noord, HGM Leukens (The Netherlands)
54 The impace of the FDA's fast track initiatives on drug safety: A case-control study [227]
J Kuesters, L Lawrie, R Wells (USA)
55 Differential migration by social deprivation of subjects with and without asthma [229]
MM Gilchrist, TM MacDonald (UK)
56 A Case-control study to determine if the addition of hydroxyurea to regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-infected individuals [231]
W McCarthy, J Gable, J Lawrence, D Rimland, M Thompson (USA)
57 Teratogenicity of antidepressants: cohort studies in two separate populations [235]
CS de Vries, L de Munck (The Netherlands) H Toft Sørensen (Denmark), TM MacDonald (UK), LTW de Jong-van den Berg (The Netherlands)
58 Reduced migration of children and young adults with chronic diseases [236]
MM McGilchrist, TM MacDonald (UK)
59 Sexual dysfunctioning in users of selective serotonin reuptake inhibitors (SSRIs) [243]
WEE Meijer, ER Heerdink, ACG Egberts, HGM Leufkens (The Netherlands)
60 Hypokaliemic medication leads to increased risk of hospitalization for arrhyhmias in patients with CHF [245]
M Bouvy, E Heerdink, RMC Herings, A Hoes, HG Leufkens (The Netherlands)
61 Safety review in 10,008 users of cansoprazole in daily practice [247]
AMC Claessens, ER Heerdink, JTHM van Eijk, CBHW Lamers, HGM Leufkens (The Netherlands)
62 Validity of pharmacy records for identification of patients with Parkinson's disease [248]
DAMC van de Vijver, BHCh Stricker, MMB Breteler, RAC Roos, AJ Porsius, A de Boer (The Netherlands)
63 Estimation of incidence and prevalence of Parkinson's disease in elderly using pharmacy records [249]
DAMC van de Vijver, RAC Roos, AJ Porsius, A de Boer (The Netherlands)
64 Antihypertensive drug treatment and the risk of severe hypoglycaemia in patients treated with oral antidiabetics [258]
K Mantey, A Bauerfeind, E Garbe (Germany), S. Suissa (Canada)
65 An epidemiological study of treated thyroid disorders: prevalence, incidence, morbidity and drug predictors [262]
EF Boumendil, C Mugnier (France)
66 Association between psychotropics and proximal femur fracture in the elderly people in Korea [266]
BJ Park, JM Bae, HW Koo (South Korea)
67 Artificial neural networks in pharmacoepidemiology: a case study on targeting patients for influenza vaccination [181]
B Suijkerbuijk, M Weeber, CS de Vries, LTW de Jong-van den Berg (The Netherlands)

Last updated: 08 June 1999


COPYRIGHT 2010 INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY
5272 River Road, Suite 630, Bethesda, MD 20816 USA
Phone: 301-718-6500, Fax: 301-656-0989, Email: ISPE@paimgmt.com
 
Privacy Policy
Terms of Use / Disclaimer Statement
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.